Enveric Biosciences, Inc (ENVB)

Etorro trading 970x250
Enveric Biosciences, Inc (ENVB) Logo

About Enveric Biosciences, Inc

Enveric Biosciences, Inc., a biotechnology company, engages in developing various cannabinoid medicines to enhance quality of life for cancer patients. It has a pipeline of development programs for radiodermatitis, glioblastoma, and chemotherapy-induced neuropathy. The company is based in Naples, Florida. Address: 4851 Tamiami Trail North, Naples, FL, United States, 34103

Enveric Biosciences, Inc News and around…

Latest news about Enveric Biosciences, Inc (ENVB) common stock and company :

Enveric Biosciences to Participate in Wonderland: Miami Conference
26 Oct, 2021 Yahoo! Finance

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in the upcoming Wonderland: Miami conference:

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
18 Oct, 2021 FinancialContent

The Week In Psychedelics Atai Launches ‘Precision Psychiatry’ Subsidiary The Psychedelics Sector ...

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing
18 Oct, 2021 Yahoo! Finance

Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.

First Week of December 17th Options Trading For Enveric Biosciences (ENVB)
15 Oct, 2021 FinancialContent

Investors in Enveric Biosciences Inc (ENVB) saw new options become available this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENVB options chain for the new December 17th contracts and identified the following call contract of particular interest.

Enveric Biosciences on the Merger with MagicMed
15 Oct, 2021 Yahoo! Finance

By Exec Edge Editorial Staff Exec Edge: How did the merger between Enveric and MagicMed come about? ​​Enveric had been looking to complement their existing product development activities, which are focused on physical symptoms, with a platform of novel psychedelics that addresses the large mental health challenges related to CNS indications such as Cancer Related […]

There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
13 Oct, 2021 FinancialContent

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking ...

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
11 Oct, 2021 Yahoo! Finance

Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference. Individual investors, institutional investors, advisors, and analysts are invited to attend the two-day program beginning Wednesday, October 13, 2021, at 9:45 a.m. ET.

Hot Penny Stocks to Buy That You Should Know About Right Now
10 Oct, 2021 FinancialContent
Best Penny Stocks To Buy This Week? 10 With Potential Biotech Catalysts
10 Oct, 2021 FinancialContent
Enveric Biosciences to Participate in Upcoming Investor Conferences in October 2021
07 Oct, 2021 Yahoo! Finance

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in two upcoming October conferences:

Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health
05 Oct, 2021 FinancialContent

Photo by Christina Victoria Craft on Unsplash The world is finally waking up to the importance of mental health. It is becoming more ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
05 Oct, 2021 FinancialContent

Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market ...

Enveric Biosciences Announces Artificial Intelligence Platform, PsyAI™, Has Identified Viable Drug Candidates from its 'Psybrary' of Psychedelic Molecular Compounds
05 Oct, 2021 Yahoo! Finance

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and oncology treatments by leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body, today announced that PsyAITM – an artificial intelligence tool designed by April19 to provide comprehensive pharmaceutical design, manufacturing, pharmacology predictive and validating methodologies – has successfully identified via

September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
02 Oct, 2021 FinancialContent

Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference
30 Sep, 2021 FinancialContent

The healthcare sector is booming and startups are the driving force behind the innovations that will affectthe future of life on ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
30 Sep, 2021 FinancialContent

Gainers OptimizeRx (NASDAQ:OPRX) stock increased by 12.12% to $84.05 during Thursday's pre-market session. The ...

18 Stocks Moving in Thursday's Pre-Market Session
30 Sep, 2021 FinancialContent

Gainers Superior Drilling Products, Inc. (NYSE: SDPI) rose 58.7% to $1.73 in pre-market trading after jumping over 23% on ...

5 Short Squeeze Penny Stocks To Buy For Under $5 Right Now
29 Sep, 2021 FinancialContent
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
20 Sep, 2021 FinancialContent

Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?

Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial
20 Sep, 2021 FinancialContent

AdvisorShares Launches First NYSE-listed Actively-managed Psychedelics ETF On Thursday, AdvisorShares launched the country’s ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
20 Sep, 2021 FinancialContent

Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The ...

Enveric Biosciences to Participate in Upcoming Investor Conferences in September 2021
20 Sep, 2021 Yahoo! Finance

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform for the mind and body using psychedelics and cannabinoids, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric Biosciences, will participate in two upcoming investor conferences:

Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
17 Sep, 2021 FinancialContent

The psychedelics sector has closed one of its largest M&As since its inception.

Enveric Biosciences Announces Closing of MagicMed Industries Acquisition
17 Sep, 2021 Yahoo! Finance

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced the closing of its acquisition of MagicMed Industries Inc. ("MagicMed"), a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules such as psilocybin, N,N-dimethyltryptamine (DMT) and other molecular derivatives with applications across mu

4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%
14 Sep, 2021 FinancialContent
72 Biggest Movers From Yesterday
14 Sep, 2021 FinancialContent

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from ...

Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week
11 Sep, 2021 FinancialContent

The performance of the psychedelic-focused index components substantially outshone the weed stocks.

48 Biggest Movers From Yesterday
10 Sep, 2021 FinancialContent

Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and ...

Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
09 Sep, 2021 FinancialContent

ByNatan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a ...

These Penny Stocks Exploded Today, What You Need to Know
09 Sep, 2021 FinancialContent

Enveric Biosciences, Inc (ENVB) is a NASDAQ Common Stock listed in , ,

970x250